Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors.

Mohrmann C.

J Pediatr Oncol Nurs. 2019 May 5:1043454219845887. doi: 10.1177/1043454219845887. [Epub ahead of print]

PMID:
31057036
2.

Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.

Tanay MA, Armes J.

Eur J Cancer Care (Engl). 2019 May;28(3):e13011. doi: 10.1111/ecc.13011. Epub 2019 Feb 20.

PMID:
30790382
3.

Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors.

Chan CW, Cheng H, Au SK, Leung KT, Li YC, Wong KH, Molassiotis A.

Eur J Oncol Nurs. 2018 Oct;36:135-141. doi: 10.1016/j.ejon.2018.09.003. Epub 2018 Sep 27.

PMID:
30322504
4.

The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.

Tanay MAL, Armes J, Ream E.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12443. Epub 2016 Jan 20. Review.

PMID:
26786536
5.
6.

Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.

Wong ML, Cooper BA, Paul SM, Abrams G, Topp K, Kober KM, Chesney MA, Mazor M, Schumacher MA, Conley YP, Levine JD, Miaskowski C.

Support Care Cancer. 2019 Feb 15. doi: 10.1007/s00520-019-04695-3. [Epub ahead of print]

PMID:
30770977
7.

Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy.

Cox-Martin E, Trahan LH, Cox MG, Dougherty PM, Lai EA, Novy DM.

Support Care Cancer. 2017 Jun;25(6):1873-1879. doi: 10.1007/s00520-017-3571-5. Epub 2017 Jan 26.

8.

Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.

Kandula T, Park SB, Cohn RJ, Krishnan AV, Farrar MA.

Cancer Treat Rev. 2016 Nov;50:118-128. doi: 10.1016/j.ctrv.2016.09.005. Epub 2016 Sep 10. Review.

PMID:
27664395
9.

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.

Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ.

Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10.

10.

Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.

Mols F, Beijers AJ, Vreugdenhil G, Verhulst A, Schep G, Husson O.

J Cancer Surviv. 2015 Sep;9(3):512-22. doi: 10.1007/s11764-015-0427-1. Epub 2015 Apr 16.

PMID:
25876556
11.
12.

A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.

Stubblefield MD, McNeely ML, Alfano CM, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463. Review.

13.

Management options for established chemotherapy-induced peripheral neuropathy.

Pachman DR, Watson JC, Lustberg MB, Wagner-Johnston ND, Chan A, Broadfield L, Cheung YT, Steer C, Storey DJ, Chandwani KD, Paice J, Jean-Pierre P, Oh J, Kamath J, Fallon M, Strik H, Koeppen S, Loprinzi CL.

Support Care Cancer. 2014 Aug;22(8):2281-95. doi: 10.1007/s00520-014-2289-x. Epub 2014 May 31. Review.

PMID:
24879391
14.

Chemotherapy-induced peripheral neuropathy: a review of recent findings.

Kim PY, Johnson CE.

Curr Opin Anaesthesiol. 2017 Oct;30(5):570-576. doi: 10.1097/ACO.0000000000000500. Review.

PMID:
28708674
15.

A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.

Bulls HW, Hoogland AI, Kennedy B, James BW, Arboleda BL, Apte S, Chon HS, Small BJ, Gonzalez BD, Jim HSL.

Gynecol Oncol. 2019 Feb;152(2):310-315. doi: 10.1016/j.ygyno.2018.12.002. Epub 2018 Dec 14.

PMID:
30558975
16.

Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.

Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, Barg FK.

Support Care Cancer. 2012 Oct;20(10):2433-9. doi: 10.1007/s00520-011-1365-8. Epub 2012 Jan 11.

PMID:
22231480
17.

Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.

Beijers AJ, Mols F, Tjan-Heijnen VC, Faber CG, van de Poll-Franse LV, Vreugdenhil G.

Acta Oncol. 2015 Apr;54(4):463-9. doi: 10.3109/0284186X.2014.980912. Epub 2014 Nov 24.

PMID:
25417732
18.

Chemotherapy-induced peripheral neuropathy: Current status and progress.

Brewer JR, Morrison G, Dolan ME, Fleming GF.

Gynecol Oncol. 2016 Jan;140(1):176-83. doi: 10.1016/j.ygyno.2015.11.011. Epub 2015 Nov 7. Review.

19.

Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer.

Kandula T, Farrar MA, Kiernan MC, Krishnan AV, Goldstein D, Horvath L, Grimison P, Boyle F, Baron-Hay S, Park SB.

Clin Neurophysiol. 2017 Jul;128(7):1166-1175. doi: 10.1016/j.clinph.2017.04.009. Epub 2017 Apr 25. Review.

PMID:
28511129
20.

Understanding the lived experience of Latino adolescent and young adult survivors of childhood cancer.

Phillips F, Jones BL.

J Cancer Surviv. 2014 Mar;8(1):39-48. doi: 10.1007/s11764-013-0310-x. Epub 2013 Sep 25.

PMID:
24065515

Supplemental Content

Support Center